Hypertension ArterialNCT07105527
Dexmedetomidine During Carotid Endarterectomy: a Registry on Safety and Satisfaction of Patients and Operators (DexTEA)
An observational study of Hypertension Arterial and Desaturation, run by Saint Camillus International University of Health Sciences at 1 site in Italy.
Trial summary
From an anesthesiological perspective, carotid endarterectomy (CEA) is an operation that is increasingly being performed with locoregional techniques and sedation. The aim of this observational study was to compare dexmedetomidine with midazolam and fentanyl during CEA in terms of perioperative adverse events… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hypertension Arterial, Desaturation, Bradycardia
- How many people
- 60 participants
- Where
- 1 siteItaly
- Study dates
- 8 Jan 2021to 2 Aug 2023
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The minimum target set to start the study was the enrolment of 60 patients to be divided equally into two groups, since our group of anaesthetists uses, without preference, two sedation protocols, in addition to cervical plexus blockade, for TEA operations in vascular surgery, both of which are approved in the literature and in internal hospital procedures
Who may be able to join
- Patients who were candidates for carotid endoarterectomy elective surgery
- Age >18yr
- Ability to provide consent for the procedure
Who cannot join
- severe liver failure (Child-Pugh classes B or C) or severe hypoproteinemia (albuminemia < 3.0 g/dl)
- age <18yr
- baseline heart rate <50 bpm; II or III grade atrioventricular block without a pacemaker
- malignant hyperthermia suspected or established
- psychiatric disorders
- emergency surgery
- inability to provide consent for the procedure
Trial locations and contacts
1 site in 1 country.
About this study
From an anesthesiological perspective, carotid endarterectomy (CEA) is an operation that is increasingly being performed with locoregional techniques and sedation. The aim of this observational study was to compare dexmedetomidine with midazolam and fentanyl during CEA in terms of perioperative adverse events, patient, anesthetist, and surgeon satisfaction, as well as the possible reduction in clamping time and the number of times additional local anaesthesia is needed.
Sixty patients listed for CEA were enrolled and two types of sedation were used, both protocols widely used in our hospital, resulting in the formation of two groups of patients. Both the intermediate and superficial cervical plexus blocks were administered, and the patients in Group 1 were sedated with midazolam and fentanyl, and Group 2 was sedated with dexmedetomidine. The investigators examined comorbidities, surgical time and clamping, and possible intraoperative use of local anaesthetics and intraprocedural complications, and follow-up at 180 days to observe any residual deficits. The data were analysed with Statistical Package for Social Science (SPSS) Statistics 25 (IBM).
Read the detailed description
Carotid endarterectomy (CEA) is one of the most common procedures in vascular surgery, along with lower limb revascularization, and endovascular surgery. It has long been considered a standard for the treatment of carotid artery disease; it is currently considered the most valid medical approach for significantly decreasing the risk of ischemic stroke in symptomatic patients and a 'quasi standard' for the treatment in patients with high-grade carotid stenosis. From an anesthesiological perspective, it is a procedure than can be approached in different ways, i.e., with the patient under a state of general anaesthesia or with locoregional techniques (with possible sedation).
Although the recent General Anesthesia vs. Local Anesthesia (GALA) trial did not demonstrate the superiority of either of the above mentioned anaesthesiological management methods for this type of surgery, there are differences between the two techniques, including the risk of postoperative cognitive impairment.
Considering the type of surgery, for greater control of haemodynamic management without excessive hypotension or hypertension, at our Unit (Sant'Eugenio Hospital, Rome, Italy), the surgery is performed through the locoregional approach, sedating the patient only to keep it still during the procedure but awake to be able to evaluate haemodynamic compensation.
Under locoregional anaesthesia, a standard for anesthesia in this procedure is the intermediate cervical| plexus block. The cervical plexus block provides anaesthesia and analgesia for neck and head surgery, including CEA procedures. Usually, along with peripheral blockade, the use of hypnotics with a sedative dosage is preferred to increase patient compliance. There are numerous drugs used to sedate patients during a procedure, starting with the most widely used drugs, such as midazolam and propofol, followed by the most recently introduced drug, dexmedetomidine. The latter is a well-known superselective a2-agonist drug with hypnotic, sedative, anxiolytic, sympatholytic and analgesic activity that suppresses the neuronal noradrenergic cascade at the locus coeruleus level without inducing respiratory depression. It has no rebound effects even after 24 hours of continuous infusion and, therefore, lends itself well to administration even for short-term procedures. It also possesses a good safety margin. The purpose of this observational study is to compare the two major sedation techniques and protocols currently used and the usefulness of dexmedetomidine during carotid endarterectomy in terms of minor and major adverse events and patient, anaesthetist, and surgeon satisfaction, as well as the possible reduction in clamping time and the number of times the surgeon needs to administer additional local anaesthesia.
Study Design and Population A single-center, prospective observational study was conducted entirely within the Sant'Eugenio Hospital. All methods were performed in accordance with the guidelines and regulations of the Declaration of Helsinki, and this prospective observational study was approved by the Independent Ethics Committee of the Sant'Eugenio Hospital. Written informed consent was obtained from all patients whose data were collected. The minimum target set to start the study was the enrolment of 60 patients to be divided equally into two groups, since our group of anesthetists uses, without preference, two sedation protocols, in addition to cervical plexus blockade, for TEA operations in vascular surgery, both of which are approved in the literature and in internal hospital procedures. This process took place from January 2021 to December 2023. All patients referred to the Vascular Surgery of the hospital who were candidates for carotid endoarterectomy surgery were considered eligible for the study. The exclusion criteria included: severe liver failure (Child-Pugh classes B or C) or severe hypoproteinemia (albuminemia < 3.0 g/di); age <18 yr; baseline heart rate <50 bpm; Il or Ill grade atrioventricular block without a pacemaker; malignant hyperthermia suspected or established; psychiatric disorders; emergency surgery, inability to provide consent for tie procedure.
Endpoints The study has primary endpoints and secondary endpoints. Primary endpoints: An anaesthetist and surgeon evaluated the usefulness of dexmedetomidine during carotid endarterectomy in terms of minor and major adverse events and patients, anaesthetists and surgeons' satisfaction. This evaluation was carried out on a graded scale from 1 to 4 (4=very satisfied, 3=satisfied, 2=slightly satisfied, 1=not satisfied), which was specifically used for this observational study.
The secondary endpoints were possible reduction in clamping time and the number of times the surgeon had to administer local anaesthesia (in our study, 0.5% lidocaine).
Anaesthesia protocol In the preprocedural phase, after signing the informed consent, the patient was cannulated with peripheral venous access and a peripheral artery for monitoring. In accordance with the perioperative fluid management in the Enhanced Recovery After Surgery (ERAS) protocol, the patient fasted with clear fluid for at least two hours before induction of anaesthesia, and Ringer's lactate was used to maintain volemia.
All patients were given a nerve block of both the intermediate and superficial cervical plexus with an ultrasound-guided needle using levobupivacaine 0.33% + mepivacaine 1.5% as a local anaesthetic, for a total volume of 15ml. The block was executed when the patient was fully awake and collaborating; in case of excessive agitation, a premedication with Midazolam 0,03 mg/kg for a maximum of 2 mg was used.
Once the preliminary phase was completed, the investigators took note of the type of sedation chosen between the two methods under analysis that are both used in our hospital, the choice of sedation protocol was at the discretion of the attending anesthetist. To standardize the procedure, for drug dosages, in addition to in-house protocols, data from the literature were used.
- GROUP 1: standard sedation with 1 mcg/kg fentanyl + 0.03 mg/kg midazolam in boluses until a Richmond Agitation-Sedation Scale (RASS) equivalent to -1/-2 was achieved.
- GROUP 2: sedation with dexmedetomidine 1 mcg/kg/h for 10 minutes and then 0.3-0.5 mcg/kg/h until RASS -1/-2.
Sedation was initiated once vital parameters were stabilized on the operating table, until the end of surgical procedure.
Typically, once on the operating table, the patient was started on continuous monitoring of cardiac, respiratory and neurological activity. At the end of surgery, the patient was then monitored over the following 4 hours in the recovery room and discharged according to Aldrete's criteria, noting the discharge times for each patient.
Data collection The data were collected from individual patient records. These included physical status, medical history, American Society of Anesthesiologists (ASA) risk score assessment, home therapy, any adverse events recorded during previous anaesthesia, recent blood test results, recent EKG and preoperative imaging (chest X-ray), if necessary. For this study, the following data were examined: medical history of comorbidities present, surgical time, clamping time, percentage of shunts and conversion to general anaesthesia, any intraoperative use of local anaesthetics (lidocaine 0.5 %), intraprocedural complications and follow-up at 180 days to observe any residual deficits.
Statistical analysis To assess the best sample size, the investigators calculated it on the number of patients with carotid pathology referred to the vascular surgery department, with a 95% confidence interval and a 5% margin of error. The study involved the enrolment of 60 patients, divided into two groups according to the anaesthesia performed in the operating room, who were compared according to the parameters assessed and recorded.
Statistical analysis was performed using chi-square tests and Fisher's exact tests for comparing proportions and Student's t tests for comparing means ÷ Standard Deviation (SD). A P value <0.05 was considered to indicate statistical significance. Statistical analysis was performed using IBM SPSS Statistics 25 (IBM).
- Conditions
- Hypertension Arterial, Desaturation, Bradycardia, Surgery (Major Vascular), Hypotension During Surgery, Dexmedetomidine Induced Sedation
- Keywords
- dexmedetomidine, cervical plexus block, sedation, satisfaction, humans, follow-up, prospective study, endarterectomy, clamping time, analgesic
- Medical subject headings
- Hypertension, Bradycardia, Patient Satisfaction, Personal Satisfaction, Nausea, Vomiting
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| sedation with 1 mcg/kg fentanyl + 0.03 mg/kg midazolam in boluses | until RASS -1/-2 | |
| sedation with dexmedetomidine 1 mcg/kg/h for 10 minutes and then 0.3-0.5 mcg/kg/h | until RASS -1/-2 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patients, anaesthetists and surgeons' satisfaction
evaluation on a graded scale from 1 to 4 (4=very satisfied, 3=satisfied, 2=slightly satisfied, 1=not satisfied),
Measured: Periprocedural
Number of Participants with Hypertension
Systolic Blood Pressure> 145 mmHg
Measured: Periprocedural
Number of Participants with Hypotension
Systolic Blood Pressure <100 mmHg
Measured: Periprocedural
Number of Participants with Bradycardia
Heart Rate <50 beats per minute
Measured: Periprocedural
Number of Participants with Nausea and/or Vomiting
Number of events
Measured: Periprocedural
Number of Participants with Desaturation
Hemoglobin saturation <88%
Measured: Periprocedural
Number of Participants with Chronic surgical site pain
Numerical Rating Scale (NRS): Zero is equivalent to no pain and 10 indicates the worst possible pain
Measured: Up to 6 months
Secondary outcomes (2)
Change in clamping time
time (minutes)
Measured: Periprocedural
Number of times the surgeon had to administer local anaesthesia
number of times the surgeon had to administer local anaesthesia (in our study, 0.5% lidocaine)
Measured: Periprocedural
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Aug 2025
- Study start8 Jan 2021
- Primary completion2 Feb 2023
- Study completion2 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (21)Papers the sponsor has linked to this study.
- Other trials for Hypertension ArterialStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 60 participants (actual)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- Saint Camillus International University of Health Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Diego Fiume, Saint Camillus International University of Health Sciences
- Investigators
- Diego Fiume, MD PhD, Study chair, UniCamillus - Saint Camillus International University of Health and Medical Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07105527
- Sponsor's protocol ID
- 0002376
- Status last verified
- Aug 2025
- First submitted
- 11 Jul 2025
- Last updated
- 12 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is no plan to share individual participant data (IPD); however, anonymized data may be made available upon reasonable request, subject to sponsor approval and ethical considerations.
Publications
Malek LA, Malek AK, Leszczynski J, Toutounchi S, Elwertowski M, Spiewak M, Domagala P. Carotid clamping time as a risk factor for early restenosis after carotid endarterectomy. Eur J Vasc Endovasc Surg. 2005 Aug;30(2):143-6. doi: 10.1016/j.ejvs.2005.04.023.
PubMed 15936960Do W, Cho AR, Kim EJ, Kim HJ, Kim E, Lee HJ. Ultrasound-guided superficial cervical plexus block under dexmedetomidine sedation versus general anesthesia for carotid endarterectomy: a retrospective pilot study. Yeungnam Univ J Med. 2018 Jun;35(1):45-53. doi: 10.12701/yujm.2018.35.1.45. Epub 2018 Jun 30.
PubMed 31620570McCutcheon CA, Orme RM, Scott DA, Davies MJ, McGlade DP. A comparison of dexmedetomidine versus conventional therapy for sedation and hemodynamic control during carotid endarterectomy performed under regional anesthesia. Anesth Analg. 2006 Mar;102(3):668-75. doi: 10.1213/01.ane.0000197777.62397.d5.
PubMed 16492813Bekker AY, Basile J, Gold M, Riles T, Adelman M, Cuff G, Mathew JP, Goldberg JD. Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol. 2004 Apr;16(2):126-35. doi: 10.1097/00008506-200404000-00004.
PubMed 15021281Sidorowicz M, Owczuk R, Kwiecinska B, Wujtewicz MA, Wojciechowski J, Wujtewicz M. Dexmedetomidine sedation for carotid endarterectomy. Anestezjol Intens Ter. 2009 Apr-Jun;41(2):78-83.
PubMed 19697824Reel B, Maani CV. Dexmedetomidine. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK513303/
PubMed 30020675Ramos-Matos CF, Bistas KG, Lopez-Ojeda W. Fentanyl. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK459275/
PubMed 29083586Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993 May;78(5):813-20. doi: 10.1097/00000542-199305000-00002.
PubMed 8098190Rahimzadeh P, Faiz SHR, Imani F, Derakhshan P, Amniati S. Comparative addition of dexmedetomidine and fentanyl to intrathecal bupivacaine in orthopedic procedure in lower limbs. BMC Anesthesiol. 2018 Jun 6;18(1):62. doi: 10.1186/s12871-018-0531-7.
PubMed 29875020Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000 Mar;90(3):699-705. doi: 10.1097/00000539-200003000-00035.
PubMed 10702460Nacif-Coelho C, Correa-Sales C, Chang LL, Maze M. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat. Anesthesiology. 1994 Dec;81(6):1527-34. doi: 10.1097/00000542-199412000-00029.
PubMed 7992922Rossel T, Kersting S, Heller AR, Koch T. Combination of high-resolution ultrasound-guided perivascular regional anesthesia of the internal carotid artery and intermediate cervical plexus block for carotid surgery. Ultrasound Med Biol. 2013 Jun;39(6):981-6. doi: 10.1016/j.ultrasmedbio.2013.01.002. Epub 2013 Mar 15.
PubMed 23499343Ramachandran SK, Picton P, Shanks A, Dorje P, Pandit JJ. Comparison of intermediate vs subcutaneous cervical plexus block for carotid endarterectomy. Br J Anaesth. 2011 Aug;107(2):157-63. doi: 10.1093/bja/aer118. Epub 2011 May 24.
PubMed 21613278Perisanidis C, Saranteas T, Kostopanagiotou G. Ultrasound-guided combined intermediate and deep cervical plexus nerve block for regional anaesthesia in oral and maxillofacial surgery. Dentomaxillofac Radiol. 2013;42(2):29945724. doi: 10.1259/dmfr/29945724. Epub 2012 Aug 29.
PubMed 22933534Pandit JJ, Satya-Krishna R, Gration P. Superficial or deep cervical plexus block for carotid endarterectomy: a systematic review of complications. Br J Anaesth. 2007 Aug;99(2):159-69. doi: 10.1093/bja/aem160. Epub 2007 Jun 18.
PubMed 17576970
Study at a glance
From the registry record, last updated by the sponsor on 12 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dexmedetomidine During Carotid Endarterectomy: a Registry on Safety and Satisfaction of Patients and Operators (DexTEA)
- ClinicalTrials.gov ID
- NCT07105527
- Acronym / sponsor ID
- 0002376
- Conditions
- Hypertension Arterial, Desaturation, Bradycardia, Surgery (Major Vascular), Hypotension During Surgery, Dexmedetomidine Induced Sedation
- Keywords
- dexmedetomidine, cervical plexus block, sedation, satisfaction, humans, follow-up, prospective study, endarterectomy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Saint Camillus International University of Health SciencesUniversity, hospital or other
- Study start
- 8 Jan 2021 (actual)
- Primary completion
- 2 Feb 2023 (actual)
- Study completion
- 2 Aug 2023 (actual)
- First posted
- 6 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
From an anesthesiological perspective, carotid endarterectomy (CEA) is an operation that is increasingly being performed with locoregional techniques and sedation. The aim of this observational study was to compare dexmedetomidine with midazolam and fentanyl during CEA in terms of perioperative adverse events, patient, anesthetist, and surgeon satisfaction, as well as the possible reduction in clamping time and the number of times additional local anaesthesia is needed.
Sixty patients listed for CEA were enrolled and two types of sedation were used, both protocols widely used in our hospital, resulting in the formation of two groups of patients. Both the intermediate and superficial cervical plexus blocks were administered, and the patients in Group 1 were sedated with midazolam and fentanyl, and Group 2 was sedated with dexmedetomidine. The investigators examined comorbidities, surgical time and clamping, and possible intraoperative use of local anaesthetics and intraprocedural complications, and follow-up at 180 days to observe any residual deficits. The data were analysed with Statistical Package for Social Science (SPSS) Statistics 25 (IBM).
Detailed description
Carotid endarterectomy (CEA) is one of the most common procedures in vascular surgery, along with lower limb revascularization, and endovascular surgery. It has long been considered a standard for the treatment of carotid artery disease; it is currently considered the most valid medical approach for significantly decreasing the risk of ischemic stroke in symptomatic patients and a 'quasi standard' for the treatment in patients with high-grade carotid stenosis. From an anesthesiological perspective, it is a procedure than can be approached in different ways, i.e., with the patient under a state of general anaesthesia or with locoregional techniques (with possible sedation).
Although the recent General Anesthesia vs. Local Anesthesia (GALA) trial did not demonstrate the superiority of either of the above mentioned anaesthesiological management methods for this type of surgery, there are differences between the two techniques, including the risk of postoperative cognitive impairment.
Considering the type of surgery, for greater control of haemodynamic management without excessive hypotension or hypertension, at our Unit (Sant'Eugenio Hospital, Rome, Italy), the surgery is performed through the locoregional approach, sedating the patient only to keep it still during the procedure but awake to be able to evaluate haemodynamic compensation.
Under locoregional anaesthesia, a standard for anesthesia in this procedure is the intermediate cervical| plexus block. The cervical plexus block provides anaesthesia and analgesia for neck and head surgery, including CEA procedures. Usually, along with peripheral blockade, the use of hypnotics with a sedative dosage is preferred to increase patient compliance. There are numerous drugs used to sedate patients during a procedure, starting with the most widely used drugs, such as midazolam and propofol, followed by the most recently introduced drug, dexmedetomidine. The latter is a well-known superselective a2-agonist drug with hypnotic, sedative, anxiolytic, sympatholytic and analgesic activity that suppresses the neuronal noradrenergic cascade at the locus coeruleus level without inducing respiratory depression. It has no rebound effects even after 24 hours of continuous infusion and, therefore, lends itself well to administration even for short-term procedures. It also possesses a good safety margin. The purpose of this observational study is to compare the two major sedation techniques and protocols currently used and the usefulness of dexmedetomidine during carotid endarterectomy in terms of minor and major adverse events and patient, anaesthetist, and surgeon satisfaction, as well as the possible reduction in clamping time and the number of times the surgeon needs to administer additional local anaesthesia.
Study Design and Population A single-center, prospective observational study was conducted entirely within the Sant'Eugenio Hospital. All methods were performed in accordance with the guidelines and regulations of the Declaration of Helsinki, and this prospective observational study was approved by the Independent Ethics Committee of the Sant'Eugenio Hospital. Written informed consent was obtained from all patients whose data were collected. The minimum target set to start the study was the enrolment of 60 patients to be divided equally into two groups, since our group of anesthetists uses, without preference, two sedation protocols, in addition to cervical plexus blockade, for TEA operations in vascular surgery, both of which are approved in the literature and in internal hospital procedures. This process took place from January 2021 to December 2023. All patients referred to the Vascular Surgery of the hospital who were candidates for carotid endoarterectomy surgery were considered eligible for the study. The exclusion criteria included: severe liver failure (Child-Pugh classes B or C) or severe hypoproteinemia (albuminemia < 3.0 g/di); age <18 yr; baseline heart rate <50 bpm; Il or Ill grade atrioventricular block without a pacemaker; malignant hyperthermia suspected or established; psychiatric disorders; emergency surgery, inability to provide consent for tie procedure.
Endpoints The study has primary endpoints and secondary endpoints. Primary endpoints: An anaesthetist and surgeon evaluated the usefulness of dexmedetomidine during carotid endarterectomy in terms of minor and major adverse events and patients, anaesthetists and surgeons' satisfaction. This evaluation was carried out on a graded scale from 1 to 4 (4=very satisfied, 3=satisfied, 2=slightly satisfied, 1=not satisfied), which was specifically used for this observational study.
The secondary endpoints were possible reduction in clamping time and the number of times the surgeon had to administer local anaesthesia (in our study, 0.5% lidocaine).
Anaesthesia protocol In the preprocedural phase, after signing the informed consent, the patient was cannulated with peripheral venous access and a peripheral artery for monitoring. In accordance with the perioperative fluid management in the Enhanced Recovery After Surgery (ERAS) protocol, the patient fasted with clear fluid for at least two hours before induction of anaesthesia, and Ringer's lactate was used to maintain volemia.
All patients were given a nerve block of both the intermediate and superficial cervical plexus with an ultrasound-guided needle using levobupivacaine 0.33% + mepivacaine 1.5% as a local anaesthetic, for a total volume of 15ml. The block was executed when the patient was fully awake and collaborating; in case of excessive agitation, a premedication with Midazolam 0,03 mg/kg for a maximum of 2 mg was used.
Once the preliminary phase was completed, the investigators took note of the type of sedation chosen between the two methods under analysis that are both used in our hospital, the choice of sedation protocol was at the discretion of the attending anesthetist. To standardize the procedure, for drug dosages, in addition to in-house protocols, data from the literature were used.
- GROUP 1: standard sedation with 1 mcg/kg fentanyl + 0.03 mg/kg midazolam in boluses until a Richmond Agitation-Sedation Scale (RASS) equivalent to -1/-2 was achieved.
- GROUP 2: sedation with dexmedetomidine 1 mcg/kg/h for 10 minutes and then 0.3-0.5 mcg/kg/h until RASS -1/-2.
Sedation was initiated once vital parameters were stabilized on the operating table, until the end of surgical procedure.
Typically, once on the operating table, the patient was started on continuous monitoring of cardiac, respiratory and neurological activity. At the end of surgery, the patient was then monitored over the following 4 hours in the recovery room and discharged according to Aldrete's criteria, noting the discharge times for each patient.
Data collection The data were collected from individual patient records. These included physical status, medical history, American Society of Anesthesiologists (ASA) risk score assessment, home therapy, any adverse events recorded during previous anaesthesia, recent blood test results, recent EKG and preoperative imaging (chest X-ray), if necessary. For this study, the following data were examined: medical history of comorbidities present, surgical time, clamping time, percentage of shunts and conversion to general anaesthesia, any intraoperative use of local anaesthetics (lidocaine 0.5 %), intraprocedural complications and follow-up at 180 days to observe any residual deficits.
Statistical analysis To assess the best sample size, the investigators calculated it on the number of patients with carotid pathology referred to the vascular surgery department, with a 95% confidence interval and a 5% margin of error. The study involved the enrolment of 60 patients, divided into two groups according to the anaesthesia performed in the operating room, who were compared according to the parameters assessed and recorded.
Statistical analysis was performed using chi-square tests and Fisher's exact tests for comparing proportions and Student's t tests for comparing means ÷ Standard Deviation (SD). A P value <0.05 was considered to indicate statistical significance. Statistical analysis was performed using IBM SPSS Statistics 25 (IBM).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 6 Months
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| sedation with 1 mcg/kg fentanyl + 0.03 mg/kg midazolam in boluses | – | –until RASS -1/-2 |
| sedation with dexmedetomidine 1 mcg/kg/h for 10 minutes and then 0.3-0.5 mcg/kg/h | – | –until RASS -1/-2 |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The minimum target set to start the study was the enrolment of 60 patients to be divided equally into two groups, since our group of anaesthetists uses, without preference, two sedation protocols, in addition to cervical plexus blockade, for TEA operations in vascular surgery, both of which are approved in the literature and in internal hospital procedures
Key inclusion criteria (3 listed)
- Patients who were candidates for carotid endoarterectomy elective surgery
- Age >18yr
- Ability to provide consent for the procedure
Key exclusion criteria (7 listed)
- severe liver failure (Child-Pugh classes B or C) or severe hypoproteinemia (albuminemia < 3.0 g/dl)
- age <18yr
- baseline heart rate <50 bpm; II or III grade atrioventricular block without a pacemaker
- malignant hyperthermia suspected or established
- psychiatric disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Patients, anaesthetists and surgeons' satisfaction
Time frame: Periprocedural
evaluation on a graded scale from 1 to 4 (4=very satisfied, 3=satisfied, 2=slightly satisfied, 1=not satisfied),
Number of Participants with Hypertension
Time frame: Periprocedural
Systolic Blood Pressure> 145 mmHg
Number of Participants with Hypotension
Time frame: Periprocedural
Systolic Blood Pressure <100 mmHg
Number of Participants with Bradycardia
Time frame: Periprocedural
Heart Rate <50 beats per minute
Number of Participants with Nausea and/or Vomiting
Time frame: Periprocedural
Number of events
Number of Participants with Desaturation
Time frame: Periprocedural
Hemoglobin saturation <88%
Number of Participants with Chronic surgical site pain
Time frame: Up to 6 months
Numerical Rating Scale (NRS): Zero is equivalent to no pain and 10 indicates the worst possible pain
2 secondary outcomes
Change in clamping time
Time frame: Periprocedural
Number of times the surgeon had to administer local anaesthesia
Time frame: Periprocedural
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Aug 2025.
- Background: PubMed 15936960Malek LA, Malek AK, Leszczynski J, Toutounchi S, Elwertowski M, Spiewak M, Domagala P. Carotid clamping time as a risk factor for early restenosis after carotid endarterectomy. Eur J Vasc Endovasc Surg. 2005 Aug;30(2):143-6. doi: 10.1016/j.ejvs.2005.04.023.
- Background: PubMed 31620570Do W, Cho AR, Kim EJ, Kim HJ, Kim E, Lee HJ. Ultrasound-guided superficial cervical plexus block under dexmedetomidine sedation versus general anesthesia for carotid endarterectomy: a retrospective pilot study. Yeungnam Univ J Med. 2018 Jun;35(1):45-53. doi: 10.12701/yujm.2018.35.1.45. Epub 2018 Jun 30.
- Background: PubMed 16492813McCutcheon CA, Orme RM, Scott DA, Davies MJ, McGlade DP. A comparison of dexmedetomidine versus conventional therapy for sedation and hemodynamic control during carotid endarterectomy performed under regional anesthesia. Anesth Analg. 2006 Mar;102(3):668-75. doi: 10.1213/01.ane.0000197777.62397.d5.
- Background: PubMed 15021281Bekker AY, Basile J, Gold M, Riles T, Adelman M, Cuff G, Mathew JP, Goldberg JD. Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol. 2004 Apr;16(2):126-35. doi: 10.1097/00008506-200404000-00004.
- Background: PubMed 19697824Sidorowicz M, Owczuk R, Kwiecinska B, Wujtewicz MA, Wojciechowski J, Wujtewicz M. Dexmedetomidine sedation for carotid endarterectomy. Anestezjol Intens Ter. 2009 Apr-Jun;41(2):78-83.
- Background: PubMed 30020675Reel B, Maani CV. Dexmedetomidine. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK513303/
- Background: PubMed 29083586Ramos-Matos CF, Bistas KG, Lopez-Ojeda W. Fentanyl. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK459275/
- Background: PubMed 8098190Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993 May;78(5):813-20. doi: 10.1097/00000542-199305000-00002.
- Background: PubMed 29875020Rahimzadeh P, Faiz SHR, Imani F, Derakhshan P, Amniati S. Comparative addition of dexmedetomidine and fentanyl to intrathecal bupivacaine in orthopedic procedure in lower limbs. BMC Anesthesiol. 2018 Jun 6;18(1):62. doi: 10.1186/s12871-018-0531-7.
- Background: PubMed 10702460Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000 Mar;90(3):699-705. doi: 10.1097/00000539-200003000-00035.
- Background: PubMed 7992922Nacif-Coelho C, Correa-Sales C, Chang LL, Maze M. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat. Anesthesiology. 1994 Dec;81(6):1527-34. doi: 10.1097/00000542-199412000-00029.
- Background: PubMed 23499343Rossel T, Kersting S, Heller AR, Koch T. Combination of high-resolution ultrasound-guided perivascular regional anesthesia of the internal carotid artery and intermediate cervical plexus block for carotid surgery. Ultrasound Med Biol. 2013 Jun;39(6):981-6. doi: 10.1016/j.ultrasmedbio.2013.01.002. Epub 2013 Mar 15.
- Individual participant dataSharing planned: No. There is no plan to share individual participant data (IPD); however, anonymized data may be made available upon reasonable request, subject to sponsor approval and ethical considerations.
Related trials for Hypertension Arterial
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Diego Fiume, MD PhD study chair
UniCamillus - Saint Camillus International University of Health and Medical Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hypertension Arterial and Desaturation, run by Saint Camillus International University of Health Sciences at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patients, anaesthetists and surgeons' satisfaction (time frame: Periprocedural). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07105527, which also lists 21 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2025.